Berkshire Biomedical is a medical device company that uses biometrics and secure systems to dispense prescribed medications accurately.
Berkshire Biomedical has raised $326K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Berkshire Biomedical's investors include National Institute on Drug Abuse (NIDA).
Berkshire Biomedical is headquartered in Dallas, United States.
Berkshire Biomedical is a medical device company that uses biometrics and secure systems to dispense prescribed medications accurately.
Berkshire Biomedical is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Berkshire Biomedical — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/berkshire-biomedical. Accessed September 30, 2026.
VCBacked. (2025). Berkshire Biomedical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/berkshire-biomedical
{{cite web |title=Berkshire Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/berkshire-biomedical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated